Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
MedStar Health, a 10-hospital system in Columbia, Md., stepped into the world of hospital fashion through a recent partnership with "healthwear" company Care+Wear to pilot a kimono-inspired hospital gown for patients to wear during their stay, The New York Times…
Here are seven articles Becker's Hospital Review published in the last week, highlighting Allergan's plan to cut 1,000 jobs and San Diego-based Dignity Health's efforts to reduce plastic straw use across the system's 39 hospitals, among other topics.
Scottsdale, Ariz.-based Primus Pharmaceuticals took its osteoarthritis treatment Limbrel off the market at the FDA's request, according to azcentral.
FDA Commissioner Scott Gottlieb, MD, on Wednesday outlined new steps the agency will take to spur more generic drug competition.
PharMEDium is recalling 55 lots of various drug products due to a lack of sterility assurance.
After a year filled with immense scrutiny over high drug prices, drug companies still made annual price hikes on many medications, although the increases were smaller than previous years, according to Reuters.
Allergan will eliminate more than 1,000 positions in anticipation of generic competition surrounding its popular dry-eye drug Restasis, reports Bloomberg.
Spark Therapeutics' Luxturna, the first gene therapy to gain FDA approval for the treatment of a rare, inherited retinal disease that can lead to blindness, will cost patients $850,000 for a one-time treatment, or $425,000 per eye, CNBC reports.
The FDA issued a Class I recall Jan. 2 for a heart device manufactured and distributed by a unit of Johnson & Johnson — citing a faulty valve, according to Reuters.
The average price hike for 20 of the nation's top-selling brand-name prescription drugs has decreased for the fifth consecutive year, according to an analysis completed by STAT.